| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.
|
JAMA
|
2013
|
4.67
|
|
2
|
Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California.
|
Gastroenterology
|
2007
|
2.76
|
|
3
|
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.
|
Gastroenterology
|
2012
|
2.68
|
|
4
|
Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
2.59
|
|
5
|
Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma.
|
J Infect Dis
|
2005
|
2.28
|
|
6
|
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study.
|
Ann Intern Med
|
2013
|
2.15
|
|
7
|
Prevention of vertical transmission of hepatitis B: an observational study.
|
Ann Intern Med
|
2014
|
2.05
|
|
8
|
Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?
|
Am J Gastroenterol
|
2011
|
1.78
|
|
9
|
Chronic kidney disease and risk of renal cell carcinoma: differences by race.
|
Epidemiology
|
2015
|
1.78
|
|
10
|
Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States.
|
Am J Gastroenterol
|
2004
|
1.72
|
|
11
|
Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis.
|
Ann Intern Med
|
2014
|
1.68
|
|
12
|
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.
|
Nat Genet
|
2013
|
1.67
|
|
13
|
Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium.
|
J Natl Cancer Inst
|
2010
|
1.60
|
|
14
|
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus.
|
Gastroenterology
|
2012
|
1.58
|
|
15
|
The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial.
|
Gastrointest Endosc
|
2002
|
1.54
|
|
16
|
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.
|
Nat Genet
|
2012
|
1.52
|
|
17
|
Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States.
|
Cancer
|
2002
|
1.48
|
|
18
|
Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.
|
Gastroenterology
|
2011
|
1.44
|
|
19
|
Racial and ethnic variations in hepatocellular carcinoma incidence within the United States.
|
Am J Med
|
2008
|
1.38
|
|
20
|
Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium.
|
Gut
|
2013
|
1.37
|
|
21
|
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium.
|
Int J Epidemiol
|
2012
|
1.30
|
|
22
|
Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.
|
Gastroenterology
|
2012
|
1.28
|
|
23
|
Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux.
|
J Natl Cancer Inst
|
2013
|
1.25
|
|
24
|
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on imaging in Barrett's Esophagus.
|
Gastrointest Endosc
|
2012
|
1.23
|
|
25
|
Adenoma detection rate and risk of colorectal cancer and death.
|
N Engl J Med
|
2014
|
1.22
|
|
26
|
Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus.
|
Gastroenterology
|
2008
|
1.19
|
|
27
|
Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium.
|
Gut
|
2011
|
1.18
|
|
28
|
Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States.
|
Dig Dis Sci
|
2009
|
1.17
|
|
29
|
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.
|
Ann Intern Med
|
2016
|
1.10
|
|
30
|
Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus.
|
Nutr Res Rev
|
2010
|
1.05
|
|
31
|
Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus.
|
Am J Gastroenterol
|
2007
|
1.04
|
|
32
|
Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus.
|
Am J Gastroenterol
|
2008
|
1.04
|
|
33
|
Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma.
|
Am J Gastroenterol
|
2007
|
1.03
|
|
34
|
Dietary patterns and the risk of Barrett's esophagus.
|
Am J Epidemiol
|
2008
|
1.03
|
|
35
|
Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis.
|
Eur J Cancer
|
2010
|
1.03
|
|
36
|
Cigarette smoking and the risk of Barrett's esophagus.
|
Cancer Causes Control
|
2008
|
0.97
|
|
37
|
Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis.
|
J Gastroenterol
|
2013
|
0.95
|
|
38
|
The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium.
|
Cancer Epidemiol
|
2012
|
0.95
|
|
39
|
Multitarget stool DNA testing for colorectal-cancer screening.
|
N Engl J Med
|
2014
|
0.94
|
|
40
|
Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus.
|
Nutr Cancer
|
2009
|
0.92
|
|
41
|
Colorectal-cancer screening--coming of age.
|
N Engl J Med
|
2013
|
0.89
|
|
42
|
The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer?
|
Clin Gastroenterol Hepatol
|
2013
|
0.87
|
|
43
|
Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis.
|
Nutr Rev
|
2013
|
0.87
|
|
44
|
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.
|
Am J Gastroenterol
|
2015
|
0.84
|
|
45
|
Approaches for classifying the indications for colonoscopy using detailed clinical data.
|
BMC Cancer
|
2014
|
0.83
|
|
46
|
Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy.
|
J Med Screen
|
2013
|
0.78
|
|
47
|
Food, the immune system, and the gastrointestinal tract.
|
Gastroenterology
|
2015
|
0.78
|
|
48
|
Understanding cancer incidence in Barrett's esophagus: light at the end of the tunnel.
|
J Natl Cancer Inst
|
2011
|
0.78
|
|
49
|
Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus.
|
Dig Dis Sci
|
2014
|
0.77
|
|
50
|
Can You Stop Surveillance After Radiofrequency Ablation of Barrett's Esophagus? A Glass Half Full.
|
Gastroenterology
|
2013
|
0.76
|
|
51
|
Barrett's esophagus: who should receive ablation and how can we get the best results?
|
Gastroenterology
|
2012
|
0.76
|
|
52
|
Vertical transmission of hepatitis B virus--in response.
|
Ann Intern Med
|
2014
|
0.75
|
|
53
|
The authors respond.
|
Epidemiology
|
2015
|
0.75
|
|
54
|
Chemoprevention in Barrett's esophagus: are we there yet, are we there yet...?
|
Clin Gastroenterol Hepatol
|
2009
|
0.75
|
|
55
|
Cancer incidence in Barrett's esophagus: does it really matter, and who's counting anyway?
|
Gastrointest Endosc
|
2008
|
0.75
|
|
56
|
Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
57
|
How should we select health professionals for studies?
|
Outcomes Manag
|
2003
|
0.75
|
|
58
|
The 75(th) Diamond Anniversary of Gastroenterology: 1943-2018.
|
Gastroenterology
|
2017
|
0.75
|
|
59
|
Accurate Identification of Colonoscopy Quality and Polyp Findings Using Natural Language Processing.
|
J Clin Gastroenterol
|
2017
|
0.75
|